kopran
Kopran is an integrated pharmaceutical manufacturer founded in 1958 in Mumbai, India, producing pharmaceutical products including antibiotics for hospitals, pharmacies, and healthcare institutions, with a planned merger into diagnostics.
- Company typePrivate
- Founded1958
- HeadquartersMumbai, India
- Headcount501–1,000
- GTM typeB2B
- OfferingHardware or Manufacturing
What kopran does
Kopran is an integrated pharmaceutical manufacturer founded in 1958 and headquartered in Mumbai, India. According to available sources, the company manufactures and supplies pharmaceutical products — including antibiotics — to a horizontal segment of healthcare providers comprising hospitals, pharmacies, and healthcare institutions. Detailed product naming, brand portfolio, manufacturing footprint, and capacity disclosures are not available in the supplied data, limiting visibility into the company's specific therapeutic or formulation mix.
The company generates revenue through the manufacture and sale of pharmaceutical products. FY2026 (year ended March 2026) revenue was Rs 681.42 crore, up 8.23% year-over-year, with Q4 FY2026 revenue of Rs 234.02 crore up 35.77% YoY. However, FY2026 net profit fell 33.26% YoY to Rs 25.73 crore despite the top-line growth, indicating margin compression. Market capitalization stood at Rs 918 crores as of April 2025, and pricing models and revenue mechanics are not publicly disclosed.
In March 2025, Kopran announced a planned merger with Kopran Laboratories Limited to enter the diagnostics market, combining pharmaceutical manufacturing with diagnostics to broaden its healthcare portfolio. Coinciding with the announcement, investor Madhusudan Kela increased his stake from 1.04% to 1.5%. Leadership is anchored by Surendra Somani as Executive Vice Chairman. No AI/ML capabilities, API platforms, or digital product surfaces are evidenced in the available data.
kopran firmographics
Firmographics- Name
- kopran
- Website
- https://kopran.com
- Company type
- Private
- Founded year
- 1958
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- Kopran is an integrated pharmaceutical manufacturer founded in 1958 in Mumbai, India, producing pharmaceutical products including antibiotics for hospitals, pharmacies, and healthcare institutions, with a planned merger into diagnostics.
- Ownership category
- akta.pro rank
kopran industry classification
Industry- Product category
- Pharmaceutical Manufacturing
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (32541), Pharmaceutical and Medicine Manufacturing (3254)
- SIC
- Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Infectious Disease & Antimicrobials Pharmaceuticals (HLAIAAAG)
- akta.pro secondary industry
- Primary Care & General Medicine Pharmaceuticals (HLAIAAAA)
Keywords
Where kopran is headquartered
LocationHeadquarters
- HQ city
- Mumbai
- HQ country
- India
- HQ region
- Asia
Markets served
kopran business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales
kopran product offering
Product offeringCore offering
Kopran is an integrated pharmaceutical manufacturer that produces and supplies drug formulations including antibiotics to healthcare providers such as hospitals, pharmacies, and healthcare institutions. The company is expanding its portfolio into the diagnostics segment through a planned merger with Kopran Laboratories Limited, announced in March 2025.
Product overview
Kopran is a pharmaceutical company. According to available sources, the company is set to merge with Kopran Laboratories Limited to expand into the diagnostics market. No specific product names, brands, or detailed product/service offerings are available in the provided source data.
Differentiator
Problem solved
Functional benefit
Products and services
- Pharmaceutical formulations (including antibiotics) Manufactured pharmaceutical drug formulations including antibiotics, supplied to hospitals, pharmacies, and healthcare institutions for patient treatment.
- Diagnostic services (planned via merger) Diagnostic services planned for introduction through the merger with Kopran Laboratories Limited, expanding Kopran's healthcare portfolio beyond pharmaceutical manufacturing.
Companies that use kopran
Customer profileSegments1 record
Ideal customer profiles1 record
kopran technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
kopran partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Kopran Laboratories LimitedcoreKopran Ltd announced a merger with Kopran Laboratories Limited to expand into the diagnostics market. This strategic merger represents a significant business expansion initiative for Kopran, combining pharmaceutical manufacturing capabilities with diagnostics to create a broader healthcare portfolio.
Scale indicators5 records
Recent moves3 records
Expansion highlights3 records
kopran competitors and assessment
Company assessmentDirect peers
- Lupin: Indian pharma manufacturer with a strong anti-infectives and antibiotics franchise plus complex generics. Comparable therapeutic mix and India-based manufacturing footprint.
- Cipla: One of India's largest generic pharmaceutical manufacturers with a broad antibiotics and respiratory portfolio. Direct overlap with Kopran in manufacturing and supplying pharma products to Indian hospitals and pharmacies.
- Aurobindo Pharma: Major Indian manufacturer of generic antibiotics and APIs with significant USFDA-approved capacity. Directly comparable as a peer Indian antibiotic and pharmaceutical manufacturer.
- Alkem Laboratories: Indian pharma company with a leading antibiotics and anti-infectives portfolio across domestic and international markets. Closely comparable in product mix and scale tier.
- Torrent Pharmaceuticals: Mid-to-large Indian pharma manufacturer with branded generics across therapeutic areas including anti-infectives. Comparable domestic-market manufacturing profile.
- Glenmark Pharmaceuticals: India-based pharma company with branded generics, APIs, and anti-infectives, comparable in scale and product mix to Kopran.
- Orchid Pharma: India-based pharma manufacturer focused on antibiotics and anti-infectives, directly comparable in therapeutic specialization and scale tier to Kopran.
Broad incumbents
- Sun Pharmaceutical Industries: India's largest pharma company by revenue, manufacturing generics and specialty drugs globally. Comparable as a broader incumbent in the same Indian pharma manufacturing space where Kopran competes.
- Zydus Lifesciences (Cadila Healthcare): Large diversified Indian pharmaceutical manufacturer with significant antibiotics, formulations, and APIs businesses. Comparable as a broader incumbent with overlapping antibiotics manufacturing.
- Dr. Reddy's Laboratories: Major Indian pharma manufacturer with global generic and API operations, including anti-infectives. Comparable as an established incumbent operating in Kopran's manufacturing space at much larger scale.
Market position
Weaknesses5 records
Competitive moat3 records
Key risks6 records
Key highlights6 records
Customer concentration
kopran social profiles
Digital presencekopran financial estimates
Financial estimateRevenue estimate
Valuation estimate
kopran leadership team
Management profileNumber of profiles
Profiles1 record
kopran funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
kopran M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about kopran
What does kopran do?
Kopran is an integrated pharmaceutical manufacturer that produces and supplies drug formulations including antibiotics to healthcare providers such as hospitals, pharmacies, and healthcare institutions. The company is expanding its portfolio into the diagnostics segment through a planned merger with Kopran Laboratories Limited, announced in March 2025.
Is kopran a public or private company?
kopran is a private company. It is classified as public and is currently operating.
When was kopran founded?
kopran was founded in 1958. It employs 501 to 1,000 people.
Where is kopran based?
kopran is headquartered in Mumbai, India, in the Asia region.
Who are kopran's main competitors?
Direct peers on record are Lupin, Cipla, Aurobindo Pharma, Alkem Laboratories, Torrent Pharmaceuticals, Glenmark Pharmaceuticals and Orchid Pharma. Broad incumbents are Sun Pharmaceutical Industries, Zydus Lifesciences (Cadila Healthcare) and Dr. Reddy's Laboratories.
Does kopran have an API?
No public API is recorded for kopran.
What industry is kopran in?
kopran's product category is Pharmaceutical Manufacturing. Its primary akta.pro industry code is HLAIAAAG, Infectious Disease & Antimicrobials Pharmaceuticals, with a secondary code of HLAIAAAA, Primary Care & General Medicine Pharmaceuticals. Its NAICS code is 325412 and its SIC code is 2834.